PhRMA submits comments to USPTO highlighting important role of patent system in medicine development

PhRMA responded to the U.S. Patent and Trademark Office ’s (USPTO) request for comments regarding USPTO initiatives to ensure the robustness and reliability of patent rights.

Source: The Catalyst - February 23, 2023 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Research and Development Patents Intellectual Property Source Type: news